TEAS Plus New Application

TUXARIN

MainPointe Pharmaceuticals, LLC

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97027082
Filing Date: 09/14/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK Tuxarin
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT Tuxarin
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK MainPointe Pharmaceuticals, LLC
*MAILING ADDRESS 2604 River Green Circle
*CITY Louisville
*STATE
(Required for U.S. applicants)
Kentucky
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
40206
PHONE 502-709-7544
*EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.mainpointepharmaceuticals.com
LEGAL ENTITY INFORMATION
*TYPE LIMITED LIABILITY COMPANY
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Kentucky
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of coughs and colds; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating allergies
*FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 10/01/2018
       FIRST USE IN COMMERCE DATE At least as early as 10/01/2018
       SPECIMEN
       FILE NAME(S)
\\TICRS\EXPORT18\IMAGEOUT 18\970\270\97027082\xml1 \ FTK0003.JPG
       SPECIMEN DESCRIPTION Screenshot of the Tuxarin product page from the MainPointe website
        WEBPAGE URL www.mainpointepharmaceuticals.com
        WEBPAGE DATE OF ACCESS 08/25/2021
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
CORRESPONDENCE INFORMATION
NAME MainPointe Pharmaceuticals, LLC
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ip@mainpointepharmaceuticals.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Frank L. Yetter/
* SIGNATORY'S NAME Frank L. Yetter
* SIGNATORY'S POSITION Vice President - Manager
SIGNATORY'S PHONE NUMBER 502-709-7544
* DATE SIGNED 09/14/2021
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97027082
Filing Date: 09/14/2021

To the Commissioner for Trademarks:

MARK: Tuxarin (Standard Characters, see mark)
The literal element of the mark consists of Tuxarin. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, MainPointe Pharmaceuticals, LLC, a limited liability company legally organized under the laws of Kentucky, having an address of
      2604 River Green Circle
      Louisville, Kentucky 40206
      United States
      502-709-7544(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations for the treatment of coughs and colds; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating allergies

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 10/01/2018, and first used in commerce at least as early as 10/01/2018, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Screenshot of the Tuxarin product page from the MainPointe website.
Specimen File1

Webpage URL: www.mainpointepharmaceuticals.com
Webpage Date of Access: 08/25/2021


For informational purposes only, applicant's website address is: www.mainpointepharmaceuticals.com
The applicant's current Correspondence Information:
      MainPointe Pharmaceuticals, LLC
       PRIMARY EMAIL FOR CORRESPONDENCE: ip@mainpointepharmaceuticals.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Frank L. Yetter/   Date: 09/14/2021
Signatory's Name: Frank L. Yetter
Signatory's Position: Vice President - Manager
Signatory's Phone Number: 502-709-7544
Signature method: Signed directly within the form
Payment Sale Number: 97027082
Payment Accounting Date: 09/14/2021

Serial Number: 97027082
Internet Transmission Date: Tue Sep 14 17:28:02 ET 2021
TEAS Stamp: USPTO/FTK-XX.XXX.XX.XX-20210914172802820
407-97027082-781de9f3ab1d882b8a5ab5c7053
939ae513d4c7c9c0ec2cfe19dcb6cc975bc3a75-
CC-28014969-20210914171837734142

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed